Printer Friendly

NOVA PHARMACEUTICAL FILES REGISTRATION STATEMENT FOR COMMON STOCK OFFERING

 NOVA PHARMACEUTICAL FILES REGISTRATION STATEMENT
 FOR COMMON STOCK OFFERING
 BALTIMORE, Dec. 4 /PRNewswire/ -- Nova Pharmaceutical Corporation (NASDAQ: NOVX) today announced that it had filed with the Securities and Exchange Commission a registration statement relating to 3,400,000 shares of common stock, 3,000,000 shares of which will be issued and sold by the company and 400,000 shares of which will be sold by two stockholders of the company.
 The offering is being managed by Tucker Anthony Incorporated. Nova has also granted the underwriters an option to purchase up to an additional 510,000 shares to cover over-allotments, if any.
 Nova is engaged in the discovery, development and commercialization of pharmaceutical products which address areas of significant medical need. The company's research and development programs are in three principal areas: inflammation, central nervous system disorders and drug delivery systems. The company's scientific strategy is to employ the tools of receptor technology, rational drug design and drug delivery technologies to develop novel therapeutic products.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 Copies of the preliminary prospectus can be obtained from Tucker Anthony Incorporated, One World Financial Center, 200 Liberty St., New York, NY 10281.
 -0- 12/4/91
 /CONTACT: Kira Bacon of Nova, 301-558-9465; or Noonan/Russo Communications, 212-979-9180, for Nova/
 (NOVX) CO: Nova Pharmaceutical Corporation ST: Maryland IN: MTC SU: OFR


GK-TS -- NY009 -- 9027 12/04/91 08:50 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 4, 1991
Words:323
Previous Article:BANTA CORPORATION ANNOUNCES DIVIDEND
Next Article:NESTOR SIGNS AGREEMENT WITH MELLON BANK
Topics:


Related Articles
ISIS PHARMACEUTICALS FILES PUBLIC OFFERING FOR 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
IMMULOGIC FILES REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
ALPHA-BETA TECHNOLOGY FILES REGISTRATION STATEMENT WITH SEC FOR INITIAL PUBLIC OFFERING OF TWO MILLION SHARES OF COMMON STOCK
WATSON PHARMACEUTICALS ANNOUNCES FILING OF REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING
LIDAK FILES REGISTRATION STATEMENT
ROBERTS PHARMACEUTICAL CORPORATION FILES PROPOSED OFFERING OF COMMON STOCK WITH SEC
SCIOS NOVA FILES REGISTRATION STATEMENT FOR SHARES ISSUED TO GENENTECH

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters